J C Martinez-Montero
Overview
Explore the profile of J C Martinez-Montero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
239
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Quintavalle C, Garofalo M, Zanca C, Romano G, Iaboni M, Del Basso De Caro M, et al.
Oncogene
. 2011 Jul;
31(7):858-68.
PMID: 21743492
Glioblastoma is the most frequent brain tumor in adults and is the most lethal form of human cancer. Despite the improvements in treatments, survival of patients remains poor. In order...
2.
Garcia J, Villuendas R, Algara P, Saez A, Sanchez-Verde L, Martinez-Montero J, et al.
Lab Invest
. 2000 Jan;
79(12):1453-9.
PMID: 10616196
p16 protein binds and inactivates cyclin D-CDK4/6 complexes, stopping the cell cycle at the G1/S boundary. Loss of p16 expression is found frequently in human cancer tissues, often resulting from...
3.
Saez A, Sanchez E, Sanchez-Beato M, Cruz M, Chacon I, Munoz E, et al.
Br J Cancer
. 1999 Jul;
80(9):1427-34.
PMID: 10424746
Cell cycle progression is regulated by the combined action of cyclins, cyclin-dependent kinases (CDKs), and CDK-inhibitors (CDKi), which are negative cell cycle regulators. p27KIP1 is a CDKi key in cell...
4.
Sanchez-Beato M, Camacho F, Martinez-Montero J, Saez A, Villuendas R, Sanchez-Verde L, et al.
Blood
. 1999 Jul;
94(2):765-72.
PMID: 10397744
p27 cyclin-dependent kinase inhibitor downregulation is essential for transition to the S phase of the cell cycle. Thus, proliferating cells in reactive lymphoid tissue show no detectable p27 expression. Nevertheless,...
5.
Sanchez E, Chacon I, Plaza M, Munoz E, Cruz M, Martinez B, et al.
J Clin Oncol
. 1998 May;
16(5):1931-9.
PMID: 9586912
Purpose: The goal of this work was to perform a comprehensive exploration of the relationship between the clinical outcome of diffuse large B-cell lymphoma (DLBCL) and the expression of a...
6.
Sanchez-Beato M, Saez A, Martinez-Montero J, Sol Mateo M, Sanchez-Verde L, Villuendas R, et al.
Am J Pathol
. 1997 Jul;
151(1):151-60.
PMID: 9212741
Cell cycle progression is regulated by the combined action of cyclins, cyclin-dependent kinases (CDKs), and CDK inhibitors (CDKIs). p27KIP1, which has a high degree of similarity with p21WAF1, is a...
7.
Sanchez-Beato M, Martinez-Montero J, Gatter K, Garcia J, Garcia J, Lloret E, et al.
Br J Cancer
. 1996 Oct;
74(7):1056-62.
PMID: 8855974
Retinoblastoma (Rb) tumour-suppressor protein plays a critical role in cell cycle control. Rb inactivation is a frequent phenomenon in tumours of different cell lineages, in which the absence of Rb...
8.
Sanchez-Beato M, Piris M, Martinez-Montero J, Garcia J, Villuendas R, Garcia F, et al.
J Pathol
. 1996 Sep;
180(1):58-64.
PMID: 8943816
Mutations in the p53 tumour suppressor gene are the most common genetic alteration found in human cancers. Most of them are accompanied by stabilization of the protein, which renders it...
9.
Piris M, Pezzella F, Martinez-Montero J, Orradre J, Villuendas R, Sanchez-Beato M, et al.
Br J Cancer
. 1994 Feb;
69(2):337-41.
PMID: 8297731
B-cell high-grade lymphomas are heterogeneous in terms of histology, clinical presentation, treatment response and prognosis. As bcl-2 and p53 gene deregulations are frequently involved in several types of lymphoid malignancies,...
10.
Martinez-Montero J, Herrington C, Stickland J, Sawyer H, Evans M, Flannery D, et al.
J Clin Pathol
. 1991 Oct;
44(10):835-9.
PMID: 1960217
The aim of this study was to optimise conditions for mRNA detection by nonisotopic in situ hybridisation (NISH) using biotinylated and digoxigenin labelled riboprobes. Because lysozyme gene transcripts are present...